secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bright Green Corp (—)
CIK:        0001886799
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001493152-25-008512
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 1.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bright Green files Chapter 11, withdraws from cannabis, to rename Drugs Made In America
--------------------------------------------------------------------------------

- Filed Chapter 11 on Feb 22, 2025; amended RSA with majority shareholder Stockwell funds $6.5M Exit Facility.
- All allowed creditor claims paid in full; shareholders retain equity with 50:1 reverse split but no dilution.
- Name change to Drugs Made In America Corp.; Stockwell becomes CEO & Executive Chair for one year.
- Agreed with DEA to withdraw all cannabis renewal applications; may reinstate later.
- Plans $3.5B owner/operator model for controlled substance production, EB-5 program, and Nasdaq relisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1886799/000149315225008512/0001493152-25-008512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1886799/000149315225008512/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer